**Question:** Tocolytic of choice in hea disease

**Core Concept:** Tocolytics are medications used to prevent premature labor and prolong the pregnancy. In patients with heart disease, the choice of tocolytic depends on the type and severity of heart disease, as well as the drug's pharmacokinetics and pharmacodynamics.

**Why the Correct Answer is Right:**

Correct Answer: **D.** Beta-agonists (e.g., terbutaline, ritodrine)

In patients with heart disease, beta-agonists are the preferred tocolytics due to their favorable pharmacokinetic and pharmacodynamic properties. Beta-agonists selectively activate beta-2 receptors, which reduces the risk of bradycardia and hypotension compared to calcium channel blockers or magnesium sulfate. Additionally, beta-agonists do not have direct effects on the heart, unlike phosphodiesterase inhibitors like sildenafil.

**Why Each Wrong Option is Incorrect:**

Option A: Calcium channel blockers (e.g., nifedipine, nicardipine)
These drugs can cause bradycardia, hypotension, and myocardial depression, making them unsuitable for patients with heart disease.

Option B: Magnesium sulfate
Magnesium sulfate can cause respiratory depression, neuromuscular blockade, and hypotension, which is not ideal in patients with heart disease.

Option C: Phosphodiesterase inhibitors (e.g., sildenafil)
Sildenafil has direct effects on the heart, increasing the risk of worsening heart failure and arrhythmias in patients with heart disease.

**Clinical Pearl:**

In patients with heart disease, tocolytics should be chosen based on their pharmacokinetics and pharmacodynamics. Beta-agonists are preferred due to their minimal impact on the heart, and they can be used in patients with heart disease without causing severe side effects.